This report provides a comprehensive guide to successfully investing in advanced therapies. It also outlines across six chapters each of the...

This five-part supply chain case study series continues with one of the transportation

The second step in the supply chain case study series is registration and workflow management

This five-part supply chain case study series begins with one of the most important factors in the success of your supply chain. Planning

Pathogen safety is a crucial but sometimes overlooked aspect of the development of advanced therapy medicinal products

In order to successfully invest in and realise the potential of advanced therapies, several technical factors must be well understood and...

The infrastructure of delivering immuno-oncology therapies is equal in importance to the science. the industry must develop clear plans for...

A video interview with Peter Olaganju, Senior Technical Director at Bluebird Bio. With every new opportunity comes great challenges

Industry leaders discuss the past, present and future of advanced therapies in this inspiring video...

Dr Alina Depkat is the customer relations manager at time:matters, a subsidiary of Lufthansa, the largest airline in Europe. She is leading...

NOVARTIS HAS MADE HISTORY AS THE FIRST PHARMA COMPANY TO GAIN APPROVAL OF A CAR-T PRODUCT BY THE FDA AND CAN BE CROWNED DEFINITIVE WINNERS OF WHAT...

KITE PHARMA’S RECENT ANNOUNCEMENT OF A MARKETING AUTHORISATION APPLICATION TO THE EMA FOR THEIR LEAD PRODUCT, AXICABTAGENE CILOLEUCEL, HAS RE...

Greg Bonfiglio is the founder and managing partner of Proteus, LLC, an investment and advisory firm that provides fund management and...

This report provides a comprehensive guide to successfully investing in advanced therapies. It also outlines across six chapters each of the...

We're keeping tabs on the innovators and disruptors for you